Cognitive Impairment in Adults with Non−Central Nervous System Cancers (PDQ®)–Health Professional Version
SECTIONS
- General Information About Cognitive Impairment in Cancer Survivors
- Normal Cognition
- Responding to Patient Reports of Cognitive Impairment
- Proactive Approaches to Cognitive Impairment
- Research Studies on Prevalence, Risk Factors, and the Natural History of Cognitive Impairment
- Interventions for Cognitive Impairment
- Changes to This Summary (11/05/2018)
- About This PDQ Summary
- View All Sections
Changes to This Summary (11/05/2018)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Added text to state that one study of 226 participants demonstrated that breast cancer patients experienced overall cognitive decline and scored consistently worse on cognitive tests, which was mediated by post-traumatic stress disorder (PTSD), indicating that PTSD may contribute in part to cognitive decline (cited Hermelink et al. as reference 8).
Added Objective cognitive deficits in breast cancer survivors receiving endocrine therapy as a new subsection.
This summary is written and maintained by the PDQ Supportive and Palliative Care Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
No hay comentarios:
Publicar un comentario